Retail pharma sales in Kazakhstan increase by one third in first six months
This article was originally published in Scrip
Retail pharmaceutical sales in Kazakhstan increased by 33% to $388.3 million in the first six months of this year compared with the same period of 2007, and the number of packs sold rose by 43% to 252.5 million, reports the local periodical Kazakhstan Pharmaceutical Herald. The average price of a drug pack fell by 7% to $1.54, but imported medicines were more than four times more expensive than domestic products, whose average price of $0.50 per pack has not changed since last year.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.